Churg Strauss Syndrome Market: By Route of Administration, By Indication, and Other Brain Diseases), By Distribution Channel, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Churg Strauss Syndrome Market Size, Share, Growth, Trends, and Global Industry Analysis: By Route of Administration (Oral, Injectable), By Indication (Acute ischemic Stroke, Cerebral Insufficiency, Alzheimer's Disease, Attention Deficit-Hyperactive Disorder (ADHD), and Other Brain Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Churg Strauss Syndrome Market size was valued at US$ 357.4 million in 2023  and is expected to reach US$ 486.4 million by 2030, at a CAGR of 4.5% from 2024 to 2030. Patients with Churg Strauss Syndrome are given prednisone, methylprednisolone, or another immunosuppressive corticosteroid drug, which is a generic pharmaceutical. The Five Factor Score (FFS) for each patient determines the medicine for Churg Strauss Syndrome. According to NORD, the estimated mean annual incidence of churg strauss syndrome is 2.4 individuals per million and can affect individuals of almost any age and has ranged from 15 to 70 years of age. Moreover, most the researchers say that the disease is undiagnosed and leads to many complications in the future years. However, lack of awareness reading autoimmune disorders and unfavorable reimbursement policies are expected to hinder the growth of the market over the future years. 

summary download arrow Download Free Sample

Global Churg Strauss Syndrome Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.5%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Churg Strauss Syndrome Market Dynamics

owing to increasing prevalence of churg strauss syndrome and other allergic reactions and asthma and rising incidence of churg strauss syndrome in children drives the growth of the churg strauss syndrome market over the forecast period.

Global Churg Strauss Syndrome Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 357.4 million

Market Size in 2030

US$ 486.4 million

Market CAGR

4.5%

By Route Administration

  • Oral
  • Injectable

By Indication

  • Acute ischemic Stroke
  • Cerebral Insufficiency
  • Alzheimers Disease
  • Attention Deficit-Hyperactive Disorder (ADHD)
  • Other Brain Diseases

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The churg strauss syndrome market provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Churg strauss syndrome market size was valued at US$ 357.4 million in 2023  and is set to reach US$ 486.4 million by 2030, at a CAGR of 4.5% [2024-2030].

The acupuncture market key players are: Heron Therapeutics, Inc. Silvergate  Grifols GlaxoSmithKline Roxane Laboratories, Inc. Hikma Pharmaceutical Corp. Rx Pharma Novartis Schein Pharmaceutical Inc.

The churg strauss syndrome market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Churg Strauss Syndrome Market Introduction 
2.1.Global Churg Strauss Syndrome Market  - Taxonomy
2.2.Global Churg Strauss Syndrome Market  - Definitions
2.2.1.Route Administration
2.2.2.Indication
2.2.3.Distribution Channel
2.2.4.Region
3.Global Churg Strauss Syndrome Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Churg Strauss Syndrome Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Churg Strauss Syndrome Market  By Route Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Oral
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Injectable
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Churg Strauss Syndrome Market  By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Acute ischemic Stroke
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cerebral Insufficiency
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Alzheimers Disease
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Attention Deficit-Hyperactive Disorder (ADHD)
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Other Brain Diseases
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Churg Strauss Syndrome Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Churg Strauss Syndrome Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Churg Strauss Syndrome Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Route Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Oral
9.1.2.Injectable
9.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Acute ischemic Stroke
9.2.2.Cerebral Insufficiency
9.2.3.Alzheimers Disease
9.2.4.Attention Deficit-Hyperactive Disorder (ADHD)
9.2.5.Other Brain Diseases
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Online Pharmacies
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Churg Strauss Syndrome Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Route Administration Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Oral
10.1.2.Injectable
10.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Acute ischemic Stroke
10.2.2.Cerebral Insufficiency
10.2.3.Alzheimers Disease
10.2.4.Attention Deficit-Hyperactive Disorder (ADHD)
10.2.5.Other Brain Diseases
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Churg Strauss Syndrome Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Route Administration Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Oral
11.1.2.Injectable
11.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Acute ischemic Stroke
11.2.2.Cerebral Insufficiency
11.2.3.Alzheimers Disease
11.2.4.Attention Deficit-Hyperactive Disorder (ADHD)
11.2.5.Other Brain Diseases
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Churg Strauss Syndrome Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Route Administration Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Oral
12.1.2.Injectable
12.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Acute ischemic Stroke
12.2.2.Cerebral Insufficiency
12.2.3.Alzheimers Disease
12.2.4.Attention Deficit-Hyperactive Disorder (ADHD)
12.2.5.Other Brain Diseases
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Churg Strauss Syndrome Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Route Administration Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Oral
13.1.2.Injectable
13.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Acute ischemic Stroke
13.2.2.Cerebral Insufficiency
13.2.3.Alzheimers Disease
13.2.4.Attention Deficit-Hyperactive Disorder (ADHD)
13.2.5.Other Brain Diseases
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Heron Therapeutics, Inc.
14.2.2.Silvergate  Grifols
14.2.3.GlaxoSmithKline
14.2.4.Roxane Laboratories, Inc.
14.2.5.Hikma Pharmaceutical Corp.
14.2.6.Rx Pharma
14.2.7.Novartis
14.2.8.Schein Pharmaceutical Inc.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Heron Therapeutics, Inc.
  • Silvergate  Grifols
  • GlaxoSmithKline
  • Roxane Laboratories, Inc.
  • Hikma Pharmaceutical Corp.
  • Rx Pharma
  • Novartis
  • Schein Pharmaceutical Inc.

Related Industry Reports

Anxiety Disorders And Depression Treatment Market

Sjogrens Syndrome Market

Brain Health Supplements Market

Global Dry Eye Syndrome Treatment Market